The specific rights and responsibilities of the individual experts are different during the assessments of health technologies performed by the Coordination Group and the evaluation of medicinal products and consultation procedures on medical devices and in vitro diagnostic medical devices performed by the European Medicines Agency and the expert panels. Therefore, an individual expert should not be prevented from being engaged in the context of the evaluation of health technologies during the centralised procedure or during the procedures pursuant to Article 54 of Regulation (EU) 2017/745 and Article 48(6) of Regulation (EU) 2017/746, on the one hand, and in a joint clinical assessment or joint scientific consultation of the same health technology, on the other hand. However, the transparency of such engagement should be ensured.
Recital 8, Regulation (EU) 2024/2699
In forcesince 18 Oct 2024